These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32557555)

  • 21. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
    Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
    Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.
    Favresse J; Eucher C; Elsen M; Tré-Hardy M; Dogné JM; Douxfils J
    Clin Chem; 2020 Aug; 66(8):1104-1106. PubMed ID: 32484887
    [No Abstract]   [Full Text] [Related]  

  • 23. Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
    Haydu JE; Maron JS; Redd RA; Gallagher KME; Fischinger S; Barnes JA; Hochberg EP; Johnson PC; Takvorian RW; Katsis K; Portman D; Ruiters J; Sechio S; Devlin M; Regan C; Blumenthal KG; Banerji A; Judd AD; Scorsune KJ; McGree BM; Sherburne MM; Lynch JM; Weitzman JI; Lei M; Kotton CN; Dighe AS; Maus MV; Alter G; Abramson JS; Soumerai JD
    Blood Adv; 2022 Mar; 6(6):1671-1683. PubMed ID: 35073571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic.
    Schneider J; Mijočević H; Ulm K; Ulm B; Weidlich S; Würstle S; Rothe K; Treiber M; Iakoubov R; Mayr U; Lahmer T; Rasch S; Herner A; Burian E; Lohöfer F; Braren R; Makowski MR; Schmid RM; Protzer U; Spinner C; Geisler F
    Respir Res; 2021 Apr; 22(1):119. PubMed ID: 33892720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Validation and Performance Evaluation of the Automated Vitros Total Anti-SARS-CoV-2 Antibodies Assay for Screening of Serostatus in COVID-19.
    Garnett E; Jung J; Tam E; Rajapakshe D; Cheney S; Brown C; Cao J; Muldrew K; Singh I; Versalovic J; Devaraj S
    Am J Clin Pathol; 2020 Nov; 154(6):742-747. PubMed ID: 32864699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study.
    Molica S; Giannarelli D; Lentini M; Zappala D; Mannella A; Loiacono D; Gianfelici V; Panduri G; Gariani I; Minchella P; Talarico F; Levato L
    Chemotherapy; 2022; 67(2):91-95. PubMed ID: 34872098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 28. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
    Demey B; Daher N; François C; Lanoix JP; Duverlie G; Castelain S; Brochot E
    J Infect; 2020 Aug; 81(2):e6-e10. PubMed ID: 32389784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
    Lin Q; Zhu L; Ni Z; Meng H; You L
    J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL experts.
    Koffman B; Mato A; Byrd JC; Danilov A; Hedrick B; Ujjani C; Roeker L; Stephens DM; Davids MS; Pagel JM; Shadman M
    Am J Hematol; 2020 Aug; 95(8):E199-E203. PubMed ID: 32356356
    [No Abstract]   [Full Text] [Related]  

  • 32. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
    Thibaud S; Tremblay D; Bhalla S; Zimmerman B; Sigel K; Gabrilove J
    Br J Haematol; 2020 Jul; 190(2):e73-e76. PubMed ID: 32433778
    [No Abstract]   [Full Text] [Related]  

  • 34. Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia.
    Lenicek Krleza J; Zrinski Topic R; Stevanovic V; Lukic-Grlic A; Tabain I; Misak Z; Roic G; Kaic B; Mayer D; Hruskar Z; Barbic L; Vilibic-Cavlek T
    Biochem Med (Zagreb); 2021 Jun; 31(2):020706. PubMed ID: 33927556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.
    Bouwman M; van Osch F; Crijns F; Trienekens T; Mehagnoul-Schipper J; van den Bergh JP; de Vries J
    BMJ Open; 2021 Oct; 11(10):e051573. PubMed ID: 34663664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reply to "CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report" Analysis of six hematological centers in Lombardy : On behalf of CLL commission of Lombardy Hematology Network (REL).
    Reda G; Noto A; Cassin R; Zamprogna G; Borella C; Scarfò L; Farina L; Molteni A; Ghia P; Tedeschi A; Montillo M;
    Leukemia; 2020 Sep; 34(9):2531-2532. PubMed ID: 32753689
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.
    Sehn LH; Kuruvilla P; Christofides A; Stakiw J
    Curr Oncol; 2020 Jun; 27(3):e332-e335. PubMed ID: 32669941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports.
    Emeribe AU; Abdullahi IN; Shuwa HA; Uzairue L; Musa S; Anka AU; Adekola HA; Bello ZM; Rogo LD; Aliyu D; Haruna S; Usman Y; Muhammad HY; Gwarzo AM; Nwofe JO; Chiwar HM; Okwume CC; Animasaun OS; Fasogbon SA; Olayemi L; Ogar C; Emeribe CH; Ghamba PE; Awoniyi LO; Musa BOP
    Int Health; 2022 Jan; 14(1):18-52. PubMed ID: 33620427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.